Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers.

Size: px
Start display at page:

Download "Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M. Super-disintegrants and dissolution enhancers."

Transcription

1 Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M Super-disintegrants and dissolution enhancers.

2 2 The Preface New: 4 dimensions of Kollidon CL standard, fine (CL-F), superfine (CL-SF) and micronized (CL-M) for your individual needs. Kollidon is well known as a universal excipient range since more than 60 years. Kollidon CL, the crosslinked PVP, is not only one of the three super-disintegrants. Moreover, Kollidon CL accelerates the dissolution and the bioavailability due to its power to form complexes with many insoluble actives. The disintegration of a tablet can be regarded as the initial step in terms of bioavailability and pharmacological action of the active substance. To achieve rapid disintegration, a disintegrant normally has to be added to the tablet formulation. The insoluble grades of Kollidon are widely used in the pharmaceuticals industry for this purpose. Furthermore, their use as pharmaceutical excipients is triggered by their ability to hydrophilize insoluble drugs, to stabilize suspensions and to form complexes, as well as by their adsorptive properties. BASF supplies Kollidon CL, Kollidon CL-F and Kollidon CL-SF as disintegrants for the pharmaceutical industry. Kollidon CL-M is usually used as a suspension stabilizer. Trademarks are owned by BASF Aktiengesellschaft Dissolution of acetylsalicylic acid tablets dissolved drug [%] % Kollidon CL without Kollidon CL time [min]

3 The Preface 3 The theory of disintegration of a tablet 1. Disintegrants are very hydrophilic. water 2. Spherical particles are uniformly distributed in the tablet. water 3. They swell during contact with water or other liquids. water 4. They significantly increase volume and disintegrate the tablet. The Market Trends Over the past few years, there has been a trend towards highly potent actives (HPAPI) and, as a consequence, a trend towards smaller tablets. The growth rate of 19 % for HPAPIs underlines the strong market need for potent disintegrants for these applications. These smaller tablets usually require disintegrants of much smaller particle size to guarantee content uniformity and to prevent the tablets from showing rough surfaces after storage. The disintegrants, however, still require the power sufficient for a rapid disintegration. Scientific investigation has indicated that the disintegration power decreases with decreasing particle size. This can be confirmed by testing our new materials Kollidon CL-F and Kollidon CL-SF. Although these materials have smaller particle sizes, they are still potent disintegrants. Furthermore, in new drug delivery technologies such as oral dispersible tablets, fast disintegrants with very good mouth feeling are in strong demand. Many of these drugs go into pediatric applications and to the OTC market in general, where good patient compliance is a precondition for the success of a drug formulation. Based on these market trends, our customers will now require new disintegrants for their new applications.

4 4 The Products The different Kollidon CL grades can best be distinguished by their different particle sizes: Average particle size range [µm] Kollidon CL Kollidon CL-F Kollidon CL-SF Kollidon CL-M 3 10 All CL-grades are crosslinked, water-insoluble polivinylpyrrolidones. There are chemical but mainly physical crosslinks. In contrast to many other disintegrants, the Kollidon CL grades are non-water-soluble. As a consequence, there is no influence on the disintegration of a tablet and the dissolution of the active due to the increased viscosity. The crospovidones act as disintegrants by absorbing water and subsequently swelling. This gain in volume is responsible for the subsequent disintegration of the tablet. However, the speed of disintegration is not only based on the swelling; * N n * O Chemical names Crospovidone Crospovidonum Insoluble polyvinylpyrrolidone Crosslinked PVP it is a combination of many factors such as: The swelling volume of the disintegrant The swelling pressure of the disintegrant The hydrophilic behavior of the disintegrant The pore sizes within the tablet The mechanical properties of the tablet Chemical crosslinks Entangled polymer chains (N-vinylpyrrolidone-polymer) A highly (mainly physically) crosslinked polymer matrix The chemical structure of Kollidon CL: It is a crosslinked homopolymer of N-vinyl-2-pyrrolidone

5

6 6 The Application In general, there is no perfect disintegrant. Disintegration is strongly dependent on the formulation of the tablet in terms of porosity, method of manufacture (wet or dry granulation) and the use of different actives and other excipients. Comparison of the materials The principle property of the materials is to decrease the disintegration time of tablets. In the figure below the three Kollidon grades are compared with their main competitive materials. Clearly, Kollidon CL shows the strongest performance. Even with a decreased particle size, the new grades Kollidon CL-F and Kollidon CL-SF show good performance, not having some of the drawbacks that Kollidon CL has, as explained above. Apart from the increase in tablet disintegration, it is even more important that the dissolution of the active ingredient is also increased. Disintegration time of direct compressed tablets with different disintegrants (6 % disintegrant in Ludipress LCE, compressed at 18 kn) 02:09 01:55 01:40 time [min:sec] 01:26 01:12 00:57 00:43 00:28 00:14 00:00 Kollidon CL Kollidon CL-F Kollidon CL-SF Crospovidone Competitor A ( µm) Crospovidone Competitor A (30 50 µm) Croscarmellosesodium Sodium starch glycolate

7 The Application 7 Dissolution of acetaminophen in deionized water (2.7 % disintegrant in a wet granulated formulation, compressed at 18 kn) 100 method: paddle 100 rpm; 37 C drug release [%] Kollidon CL Kollidon CL-F Kollidon CL-SF Crospovidone Competitor A ( µm) Croscarmellose-sodium Crospovidone Competitor A (30 50 µm) Sodium starch glycolate time [min] The dissolution curves show that Kollidon CL has the best performance, followed by Kollidon CL-F and Kollidon CL-SF. In some cases customers may wish to have a slightly slower disintegration for specific applications; the new materials could help to produce a dissolution profile fitted to such a requirement, e. g. for generics. A requirement of many customers is that the tablets show a smooth surface after storage in multidose containers. Because the Kollidon CL grades are very hydrophilic, they tend to absorb water and thus produce a rough surface due to swelling. In the case of film tablets, this might cause cracks in the film. Tablets produced with fine materials Kollidon CL-F and Kollidon CL- SF produce a very smooth surface.

8 8 The Application Kollidon CL Kollidon CL Kollidon CL is used as the standard disintegrant for all kinds of fast dispersible tablet formulations. For many years, companies have known just how well the material performs. The main reasons for using Kollidon CL are the advantages provided compared to other materials like e. g. starch or cellulose derivatives. When used as disintegrants, these products tend to form highly viscous systems when in contact with water. This is in contrast to Kollidon CL, which is insoluble and which as a consequence does not slow down the dissolution of a oral dosage form but might even increase the release of the active ingredient. In some cases where Kollidon CL does not meet the requirements of the customers e. g. for wet granulation with a large amount of solvent, Kollidon CL-F or Kollidon CL-SF are suitable replacements µm µm µm Kollidon CL

9 The Application Kollidon CL-F 9 Kollidon CL-F Kollidon CL-F is the perfect alternative when formulators are looking for a disintegrant with strong disintegration power in combination with a smooth tablet surface. With Kollidon CL, however, some problems might occur when the tablet is very hygroscopic and packed in a multi-dose container. Capsules filled with microtablets (capsule size 00 4) 23.5 mm 8.5 mm 5.2 mm 14.1 mm µm µm µm Kollidon CL-F Kollidon CL-F should be used for the development of small tablets when fine particles are required to avoid content uniformity problems. Furthermore, the material is able to absorb large amounts of solvent. This can be beneficial when customers use such large amounts during a wet granulation step where large amounts of solvent are needed e. g. for dissolving the active. However, in some cases, Kollidon CL-SF might be the best solution for a specific application. Microtablets, 2 mm diameter

10 10 The Application Kollidon CL-SF Kollidon CL-SF Kollidon CL-SF has advantages when it comes to special applications, for example oral fast dispersible tablets. The main reason is reliable disintegration power in combination with a very smooth cream-like mouth feel. Nevertheless, in some cases, Kollidon CL-SF might be used as a regular disintegrant when customers have a wet granulation process that uses large amounts of solvent. Kollidon CL-SF has the highest solvent (water/ethanol etc.) uptake capacity of all the crospovidones produced by BASF µm Kollidon CL-SF µm µm

11

12 12 The Examples Formulation of Nifedipine tablets (granulated) Nifedipine 10 mg (5.85 %) Kollidon VA mg (5.85 %) Ludipress LCE 100 mg (58.50 %) Kollidon CL-F or -SF 50 mg (29.22 %) Magnesium stearate 1 mg (0.58 %) Tablet weight 171 mg (100 %) Formulation of Haloperidol tablets (direct tabletting) Haloperidol 2 mg (2.5 %) Ludipress LCE 75 mg (93.75 %) Kollidon CL 2.5 mg (3.12 %) Magnesium stearate 0.5 mg (0.63 %) Tablet weight 80 mg (100 %)

13 The Overview 13 As far as disintegrants are concerned, there are many products in the market starting with the basic starches derived from maize, rice, corn and potato. They have been used for a long time but have certain disadvantages in terms of the amount that is needed to ensure disintegration. One particular disadvantage of disintegrants based on starch and of the cellulose derivatives is the increase of viscosity after disintegration. The first question is always related to the real effect of the disintegrant on the disintegration time. In the figure, the disintegration test results of tablets produced with granulated material are shown. These clearly show the strengths of the crospovidones, especially the Kollidon CL grades. Disintegration of tablets made of granules (2,7 % disintegrant extragranular use, compressed at 18 kn) :56 disintegration time [min] :55 Kollidon CL 11:08 Kollidon CL-F 09:06 Kollidon CL-SF 12:46 12:30 Kollidon CL-M Crospovidone Competitor A ( µm) 22:37 Crospovidone Competitor A (30 50 µm) 23:28 Croscarmellosesodium Sodium starch glycolate

14 14 The Overview Disintegrants on the market Required Disinte- Hardness Issues during % gration power of the tablets storage at 1: low high humidity 10: high Starches Low * Starch derivatives Sodium starch glycolate High Brown spots Cellulose derivatives Carmellose-sodium Croscarmellose-sodium Carmellose-calcium HPC Medium * High Brown spots (most cases 2 3) Medium * High * Crospovidone grades Compet. A ( µm) Compet. A (30 50 µm) Kollidon CL Kollidon CL-F Kollidon CL-SF High Rough surface High Smooth surface Medium Rough surface High Smooth surface Very high Smooth surface *: Not tested

15 The Summary 15 The following table describes the advantages of each material for our customers the pharmaceutical industry and their customers, the patients. Benefits for manufacturers Benefits for patients Main applications Kollidon CL The super-disintegrant, Fast drug absorption Disintegrant for very fast disintegration for most APIs standard tablets Kollidon CL-F No content uniformity Easy to swallow Small tablets, problems especially in due to tablet size tablets stored under small tablets high humidity Kollidon CL-SF Perfect for fast Best mouthfeel Fast dispersible dispersible tablets, tablets, excellent tablet surface intragranular disintegrant for wet granulation Kollidon CL-M Stable dispersions Easy to redisperse Suspensions Depending on the preferred disintegration and dissolution rate, our customers can select the excipient of choice from our comprehensive product range.

16 Please write in block letters. Thank you. Title/Name Department Please apply postage stamp. Company Address Town Country Telephone Fax Reply card BASF Aktiengesellschaft G-MEP/ME Li 554 Attn: Dr. Hubertus Folttmann Carl-Bosch-Straße 64 D Limburgerhof Germany Fax Reply Local contact: or Headquarter Germany: Please complete, copy and fax to us, or detach the postcard and send it to us. Please send the following information: Technical information on Kollidon CL grades. Sample of Kollidon CL, 0.5 kg. Sample of Kollidon CL-F, 0.5 kg. Sample of Kollidon CL-SF, 0.2 kg. Sample of Kollidon CL-M, 0.5 kg. Technical information on Kollidon VA 64. Technical information on Kollidon VA 64 Fine. Technical information on Ludipress. DVD Pharmaceutical Excipients by BASF Fine Chemicals. Newsletter ExAct (Excipients & Actives for Pharma). Please contact me, I would like to know more about Kollidon CL.

17 Please send the following information: Technical information on Kollidon CL grades. Sample of Kollidon CL, 0.5 kg. Sample of Kollidon CL-F, 0.5 kg. Sample of Kollidon CL-SF, 0.2 kg. Sample of Kollidon CL-M, 0.5 kg. Technical information on Kollidon VA 64. Technical information on Kollidon VA 64 Fine. Technical information on Ludipress. DVD Pharmaceutical Excipients by BASF Fine Chemicals. Newsletter ExAct (Excipients & Actives for Pharma). Please contact me, I would like to know more about Kollidon CL. We look forward to answering any questions you may have. Please fill in the postcard, detach it and return it to the address overleaf. Please contact your local BASF company or one of the following regional centers: Asia BASF Asia Pacific Regional HQ Pharma Solutions Dr. Danilo Mercado BASF East Asia Regional Headquarters Ltd. 45th Floor, Jardine House, No.1 Connaught Place, Central, Hong Kong Phone: Fax.: mercadd@ basf-east-asia.com.hk Europe BASF Aktiengesellschaft MEE/HP J 550 Mr. Peter Hoffmann D Ludwigshafen Germany Phone: Fax: peter.01.hoffmann@ basf.com North America BASF Corporation Pharma Solutions Mr. Javier Beeck 100 Campus Drive Florham Park, NJ USA Phone: Fax: javier.beeck@ basf.com South America BASF S.A. Human Fine Chemicals Ms. Vanessa Occhipinti Estrada Samuel Aizemberg, São Bernardo do Campo SP Brazil Phone: Fax: vanessa.occhipinti@ basf.com

18 Excipients Kollidon grades Group of povidone and copovidone products suitable mainly as tablet binders, crospovidone as tablet disintegrant and dissolution enhancer. Kollidon SR Matrix sustained release polymer. Ludipress grades Direct tabletting aids for faster product development and speedier processing. Kollicoat grades Range of aqueous based film formers, cost efficient and ecological. Cremophor grades and Solutol HS 15 Range of different ethoxylated emulsifiers and solubilizers suitable for topical, oral and parenteral formulations. Soluphor P 2-pyrrolidone. Lutrol grades Range of PEGs (Lutrol E range) and poloxamers (Lutrol F range) for a wide variety of pharmaceutical dosage forms. Actives Ephedrines Pseudoephedrines Theophylline Caffeine Isotretinoin Tretinoin Ibuprofen Dobutamine Dopamine Isometheptene mucate Oxymetazoline PVP-Iodine Selegiline Xylometazoline APIs by Orgamol Vitamins Contract Manufacturing Value Added Pharma Solutions by BASF BASF offers more than cgmp quality and supply safety: technical expertise. Our technical service is always at your side. BASF wishes to create a prosperous and sustainable future with you as our customer and partner. BASF Aktiengesellschaft Fine Chemicals Division Pharma Solutions Ludwigshafen Germany Fax pharma.solutions@basf.com BASF the world s leading chemical company can look back on well over 140 years of success and has attained an outstanding position as a reliable partner. Our portfolio for the pharmaceutical industry comprises a comprehensive range of major and new active ingredients and excipient brands. MEMP e-00

19

20

21

22

23

24

25

26

27

28

29

30

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy Dr. Philipp Hebestreit, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.

More information

Soluplus The Solid Solution Opening New Doors in Solubilization.

Soluplus The Solid Solution Opening New Doors in Solubilization. Soluplus The Solid Solution Opening New Doors in Solubilization. Dr. Shaukat Ali, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active

More information

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations TECHNICAL INFORMATION 1426 RxCIPIENTS FM 1 A versatile excipient for orally disintegrating tablet (ODT) formulations Table of contents 1 Introduction 3 2 Mode of action and advantages of RxCIPIENTS FM

More information

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies VIVAPHARM PVP/VA Copovidone, Ph.Eur. USP/NF, JPE, E 1208, FCC The Ultimate Tablet Binder for All Processing Technologies Direct Compression Dry Granulation Hot Melt Extrusion Wet Granulation VIVAPHARM

More information

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant EXCIPIENTS STARCH 1500 Proven and Trusted Excipient for Performance and Versatility Effective and economical disintegrant Excellent stability for moisture sensitive drugs Manufactured exclusively for the

More information

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE

Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Excipients make the difference! Dr. Felicitas Guth Global Technical Service Excipients Pharma Ingredients & Services BASF SE Paradigm shift in pharmaceutical development Traditional medicinal products

More information

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability Andreas Gryczke, an enabler in excipients Pharma Ingredients & Services. Welcome to more opportunities.

More information

STARCH Application Data

STARCH Application Data STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone

More information

Librel. Highly soluble chelates for plant nutrition

Librel. Highly soluble chelates for plant nutrition Librel Highly soluble chelates for plant nutrition A great mixer, tackling micronutrient deficiencies effortlessly Microgranular Librel range dissolves rapidly and completely and offers unrivalled compatibility

More information

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products 57. Starch Convention, Detmold, April 26-28, 2006 K.-J. Steffens Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products Starches, Pharmaceutical Applications _ Starches

More information

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process Direct With the right ingredients it s a simple, cost-effective manufacturing process TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Speed and savings sounds good to us

More information

Volker Bühler. Pharmaceutical Technology of BASF Excipients. Pharma Ingredients &Services. Welcome to more opportunities.

Volker Bühler. Pharmaceutical Technology of BASF Excipients. Pharma Ingredients &Services. Welcome to more opportunities. Volker Bühler Pharmaceutical Technology of BASF Excipients Pharma Ingredients &Services. Welcome to more opportunities. Volker Bühler Pharmaceutical Technology of BASF Excipients 3 rd revised edition June

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. Tailormade formulated. s film coating products are one-step coating

More information

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical Excipient Quality & Trouble Shooting By Seema Trivedi GM, Technical Back Ground The Society for Pharmaceutical Dissolution Science (SPDS) had held its 6th Annual International Convention Disso India -

More information

Easy, fast and reliable!

Easy, fast and reliable! Product Overview Easy, fast and reliable! Special easy-to-use preparations for film coating, sugar-coating, colouring and tabletting. s film coating products are one-step coating systems for pharmaceutical

More information

The unlocked synergy of DFE Pharma MCC

The unlocked synergy of DFE Pharma MCC The unlocked synergy of DFE Pharma MCC We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder inhalation formulations.

More information

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS Research Article A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS K. P. R. Chowdary *, Tanniru Adinarayana, T. Vijay, Mercy. R. Prabhakhar

More information

Critical material properties for the design of robust drug products : excipient functionality related characteristics

Critical material properties for the design of robust drug products : excipient functionality related characteristics Critical material properties for the design of robust drug products : excipient functionality related characteristics Dr Liz Meehan, Pharmaceutical Development, Macclesfield UK 1 Excipients Definition

More information

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1 Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1 ASAHI KASEI CHEMICALS CORPORATION CEOLUS R&D DEPARTMENT 1 CONTENTS General

More information

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS 211 7. SUMMARY, CONCLUSION AND RECOMMENDATIONS Drug absorption from the gastro intestinal tract can be limited by various factors with the most common one being poor aqueous solubility and poor permeability

More information

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets.

To study the effect that hydroxypropylcellulose (HPC) polymer molecular weight (MW) exerts on drug release rates and mechanism from matrix tablets. PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-029-1 (Supersedes PTR 029) Page 1 of 7 Hydroxypropylcellulose in Modified Release Matrix Systems: Polymer Molecular Weight Controls

More information

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Biopharmaceutics Dosage form factors influencing bioavailability Lec:5 Ali Y Ali BSc Pharmacy MSc Industrial Pharmaceutical Sciences Dept. of Pharmaceutics School of Pharmacy University of Sulaimani 09/01/2019

More information

Pharma Ingredients & Services. Ibuprofen. Technical Information. = Registered trademark of BASF group USP, Ph. Eur., JP

Pharma Ingredients & Services. Ibuprofen. Technical Information. = Registered trademark of BASF group USP, Ph. Eur., JP Technical Information Ibuprofen April 2010 Supersedes issue dated January 2010 03_030720e-10/Page 1 of 14 = Registered trademark of BASF group USP, Ph. Eur., JP Pharma Ingredients & Services 03_030720e-10

More information

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ QbD Approach to Formulation of Hydrophilic Matrix Using Sample Kit of Hypromellose [Metolose SR] DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa,

More information

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation Animal Health Product Overview Liquids and Gels Solid Dosage Forms Premixes Dietary Fibers Customize Your Formulation ANIMAL HEALTH Product Overview General Information Liquids and Gels Healthcare is essential

More information

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING

SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING SUSTAINED RELEASE TABLETS USING A PVA DC FORMULATION RESISTANT TO ALCOHOL INDUCED DOSE DUMPING Dr. Dieter Lubda MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany Agenda: Sustained release

More information

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet

Effect of superdisintegrants and their mode of incorporation on disintegration time and release profile of carbamazepine from immediate release tablet Journal of Applied Pharmaceutical Science Vol. 3 (5), pp. -84, May, 213 Available online at http://www.japsonline.com DOI: 1.7324/JAPS.213.3515 ISSN 2231-3354 Effect of superdisintegrants and their mode

More information

REVISION OF MONOGRAPH ON TABLETS. Tablets

REVISION OF MONOGRAPH ON TABLETS. Tablets March 2011 REVISION OF MONOGRAPH ON TABLETS Final text for addition to The International Pharmacopoeia This monograph was adopted by the Forty-fourth WHO Expert Committee on Specifications for Pharmaceutical

More information

FLORITER. New Technology for Innovative Formulation Design.

FLORITER. New Technology for Innovative Formulation Design. FLORITER New Technology for Innovative Formulation Design www.tomitaph.co.jp FLORITE Dramatically Change Your Formulation FLORITE is synthetic Calcium Silicate with exceptional liquid absorbency and excellent

More information

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Dow Wolff Cellulosics Pharmaceutical Excipients Using ingenuity and savvy to help design healthcare solutions TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow Enhancing

More information

Formulation and Evaluation

Formulation and Evaluation Chapter-5 Formulation and Evaluation 5.1 OBJECTIVE After successful taste masking and solubility enhancement of drugs in preliminary studies, by using Mannitol Solid Dispersion, next step includes the

More information

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig

Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems D. Tewari, R. K. Lewis, W. W. Harcum and T Dürig PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-069-1 (Supersedes PTR-069) Page 1 of 8 Hydrodynamic Robustness of Hypromellose and Methylcellulose Based Modified Release Matrix Systems

More information

Kollicoat Smartseal 30 D Active Protection

Kollicoat Smartseal 30 D Active Protection Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active Ingredients Kollicoat Smartseal 3 D Active Protection Breaking new ground in taste masking and moisture

More information

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER Life-saving pharmaceuticals start with high-quality ingredients CONFIDENCE STRAIGHT FROM THE SOURCE From oral dosage excipients (Rx, Gx, nutraceuticals

More information

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2014; 4(1):47-51 Research Article FORMULATION AND EVALUATION

More information

>>> Oral Formulation Optimization. Introduction. A Tiered Approach for Identifying Enabling Formulations

>>> Oral Formulation Optimization. Introduction. A Tiered Approach for Identifying Enabling Formulations Application Note #28-DMPK-3 >>> Oral Formulation Optimization Introduction Among the criteria required of compounds advancing from drug discovery programs, adequate systemic exposure (plasma concentrations

More information

Optimization of valsartan tablet formulation by 2 3 factorial design

Optimization of valsartan tablet formulation by 2 3 factorial design Research Article ISSN: 0974-6943 K. P. R. Chowdary et al. / Journal of Pharmacy Research 2014,8(9, Available online through http://jprsolutions.info Optimization of valsartan tablet formulation by 2 3

More information

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac

A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac Asian Journal of Chemistry Vol. 22, No. 6 (2010), 4239-4244 A Comparative Evaluation of Cross Linked Starch Urea-A New Polymer and Other Known Polymers for Controlled Release of Diclofenac K.P.R. CHOWDARY*

More information

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications Hypromellose CONTENTS PAGE 2 Preface Matrix system Selection of METOLOSE grades Specifications Properties Powder Solution Application Related Patents 3 4-5 6 8 10 13 14 17 Please note: The information

More information

4. Monitoring of dissolution induced changes in film coat

4. Monitoring of dissolution induced changes in film coat 4. Monitoring of dissolution induced changes in film coat composition 4.1 Introduction As membrane controlled drug delivery coatings are subjected to changes in coating composition, it is necessary to

More information

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section.

ANNEXURE -2. Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2. EXCIPIENTS PROFILES ANNEXURE -2 Excipients profiles of Compritol ATO 888, Gelucire 43/01, HPMC and PVP and have been described in the following section. 2.1. COMPRITOL 888 Non proprietary names BP:

More information

Rationale of and Experience with the Expert System

Rationale of and Experience with the Expert System Rationale of and Experience with the Expert System Professor Mitsuru HASHIDA Roland DAUMESNIL Lecture presented during the Controlled Release Society Symposium Optimization of Oral Drug Delivery Hong Kong

More information

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS Int. J. Chem. Sci.: 10(4), 2012, 1934-1942 ISSN 0972-768X www.sadgurupublications.com STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS K. VENUGOPAL * and K. P. R. CHOWDARY a Nirmala College

More information

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating

LYCOAT. New solutions for Film Coating from Roquette. LYCOAT for quicker quality coating LYCOAT New solutions for Film Coating from Roquette LYCOAT for quicker quality coating Roquette LYCOAT New solutions for Film Coating from Roquette LYCOAT New solutions for Film Coating Film coating, the

More information

CHEWABLE SOFTGEL TECHNOLOGY

CHEWABLE SOFTGEL TECHNOLOGY CHEWABLE SOFTGEL TECHNOLOGY PROCAPS AT A GLANCE Procaps is a Pharmaceutical Group dedicated to delivering innovation, health and Nutrition. We work hand in hand with our customers and develop products

More information

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence YOUR ORAL SOLID DOSE DFE Pharma globally supplies a unique, broad portfolio of key excipients including lactose, MCC, superdisintegrants and starches. Innovative products such as SuperTab 24AN and SuperTab

More information

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries. Technical Information Kolliwax HCO September 2015 03_150617e_00/Page 1 of 8 WF-No. 129938 = Registered trademark in many countries Hydrogenated castor oil powder for pharmaceutical use 03_150617e_00 September

More information

Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD

Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD Combining HME & Solubilization: Soluplus - The Solid Solution By: Hendrik Hardung, PhD; Dejan Djuric, PhD; and Shaukat Ali, PhD INTRODUCTION Drug solubilization has drawn attention in recent years because

More information

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium Available online on www.ijddt.com International Journal of Drug Delivery Technology 214; (3); 98-13 Research Article ISSN: 97 441 Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast

More information

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012 STUDIES ON EFFECT OF SUPERDISINTEGRANTS ON ETORICOXIB TABLET FORMULATIONS Chowdary K. P. R 1, Venugopal. K *2 1 College of Pharmaceutical Sciences, Andhra University, Vishakapattanam. 2 * Nirmala college

More information

Global Oilfield Solutions. Demulsifiers for the Oil Industry: Basorol

Global Oilfield Solutions. Demulsifiers for the Oil Industry: Basorol Demulsifiers for the Oil Industry: Basorol The most important objective of any oil production facility is the separation of water from produced crude. The quick and efficient breaking of these emulsions

More information

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET G ARJUN 1*, M.SRAVAN PRASAD 1, D SANTHOSHA 1 AND G.ACHAIAH 2 1 Nalanda college of pharmacy, Osmania University, Nalgonda, India. 2 University College of Pharmaceutical Sciences, Kakatiya University, Warangal,

More information

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES Int. J. Chem. Sci.: 10(1), 2012, 297-305 ISSN 0972-768X www.sadgurupublications.com FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES K. P.

More information

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

Formulation and Development of Sustained Release Tablets of Valsartan Sodium INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Research Article Formulation and Development of Sustained Release Tablets of Valsartan Sodium G. Sandeep * and A. Navya Department of

More information

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig

Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig PHARMACEUTICAL THNOLOGY REPORT Consumer Specialties ashland.com PTR 11 Page 1 of 5 Evaluation of different binders for roller compaction R. Wang, W. Liu, T. Durig Objectives When preparing tablets by roller

More information

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride. Available online on www.ijcpr.com International Journal of Current Pharmaceutical Review and Research, 3(4), 105-109 Research Article ISSN: 0976-822X Formulation and Evaluation of Gastroretentive Dosage

More information

SUMMARY AND CONCLUSION

SUMMARY AND CONCLUSION SUMMARY AND CONCLUSION 8 SUMMARY AND CONCLUSIONS In spite of the many challenges faced by researchers while designing an effective, reproducible and stable dosage form, oral dosage forms continued to maintain

More information

SENTRY TM POLYOX Water Soluble Resins

SENTRY TM POLYOX Water Soluble Resins SENTRY TM POLYOX Water Soluble Resins Technical Information on Stability Introduction Key Points Antioxidants SENTRY POLYOX WSR resins consist of a family of high molecular weight polyethers with nominal

More information

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets

Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution of Topiramate Immediate Release Tablets International Journal of Pharmaceutical Sciences and Nanotechnology Volume 2 Issue 2 July September 2009 Research Paper The Effect of Different Superdisintegrants and their Concentrations on the Dissolution

More information

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation

The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation METHOCEL Premium Cellulose Ethers Application Data The Relevance of USP Methodology in the Development of a Verapamil Hydrochloride (240 mg) Extended Release Formulation INTRODUCTION Hydrophilic matrices

More information

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box

FROM SOLVENT TO AQUEOUS COATINGS. (Out of the Frying Pan...) Ralph E. Pondell. Coating Place, Inc. P.O. Box 84-1 FROM SOLVENT TO AQUEOUS COATINGS (Out of the Frying Pan...) Ralph E. Pondell Coating Place, Inc. P.O. Box 930310 Verona, WI 53593 A number of reasons exist for the current high level of interest in

More information

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1

(12) Patent Application Publication (10) Pub. No.: US 2003/ A1 US 2003.01.18647A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2003/0118647 A1 Seth (43) Pub. Date: (54) EXTENDED RELEASE TABLET OF Publication Classification METFORMIN (51)

More information

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009 Co-Processed Excipients: Regulatory Challenges Carl Mroz Colorcon Limited June 2009 What is a Co-Processed excipient? Several types of excipient contain multiple components by design Use of processing

More information

Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone

Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone February 2002 Chem. Pharm. Bull. 50(2) 193 198 (2002) 193 Studies of Rapidly Disintegrating Tablets in the Oral Cavity Using Co-ground Mixtures of Mannitol with Crospovidone Toshifusa SHU,* Hideshi SUZUKI,

More information

GLYCOLYS

GLYCOLYS ROQUETTE WORLDWIDE EUROPE FRANCE Roquette Frères Corporate Headquarters 62080 Lestrem cedex - France Telephone: + 33 3 21 63 36 00 Fax: + 33 3 21 63 38 50 FINLAND Roquette Nordica Oy PL 11 P.O.B FIN-02171

More information

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch

Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch Abstract K.P.R. Chowdary et al. / International Journal of Pharma Sciences and Research (IJPSR) Formulation Development of Aceclofenac Tablets Employing Starch Phosphate -A New Modified Starch K.P.R. Chowdary*,

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredients (APIs): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:

More information

Continuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016

Continuous Granulation Using a Twin-Screw Extruder. Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016 Continuous Granulation Using a Twin-Screw Extruder Lin Zhu, Ph.D. Manufacture Science and Technology AbbVie June, 2016 What is a twin screw extruder and how to use it for continuous granulation? Dry feed:

More information

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN: Review Article International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(6): 207-213 A CONCISE REVIEW ON NOVEL

More information

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD Int. J. Chem. Sci.: 6(3), 2008, 1270-1275 FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD K. P. R. CHOWDARY, P. TRIPURA SUNDARI and K. SURYA

More information

Formulation and evaluation of oro-dispersible tablets of lafutidine

Formulation and evaluation of oro-dispersible tablets of lafutidine Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):226-235 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4

More information

Bioavailability enhancement of poorly soluble APIs. Enhanced solubilization out of solid glassy solutions prepared by Hot-Melt Extrusion

Bioavailability enhancement of poorly soluble APIs. Enhanced solubilization out of solid glassy solutions prepared by Hot-Melt Extrusion Pharma Ingredients & Services. Welcome to more opportunities. Custom Synthesis Excipients Active Ingredients ExActConcepts Example: Itraconazole Bioavailability enhancement of poorly soluble APIs Enhanced

More information

Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System

Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System Opadry Enteric Application Data Acrylic-Based Coating System Development of USP Delayed Release Aspirin Tablets using Opadry Enteric, Acrylic-Based Coating System INTRODUCTION Acetylsalicylic acid (aspirin)

More information

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION

CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION CHAPTER 5: FORMULATION OF SOLID DOSAGE FORM (TABLET & CAPSULES) INTRODUCTION LEARNING OBJECTIVES The objectives of this unit are to: Understand the formulation of solid dosage form. Understand the characteristic

More information

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients LubriTose Mannitol Michael Crowley, Director of R&D, Excipients Introduction Michael Crowley Director of R&D Excipients 158 St. Highway 320 Norwich, NY 13815 PH 315-802-5970 Michael.Crowley@Kerry.com 2

More information

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency

Pharma & Food Solutions. POLYOX TM Water Soluble Resins Combining Flexibility with Consistency Pharma & Food Solutions POLYOX TM Water Soluble Resins Combining Flexibility with Consistency POLYOX 9-13 POLYOX 9-13 POLYOX * are nonionic poly (ethylene oxide) polymers that meet all the specifications

More information

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( )

(51) Int Cl.: A61K 9/20 ( ) A61K 31/41 ( ) (19) TEPZZ 94677_A_T (11) (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 2.11.1 Bulletin 1/48 (1) Int Cl.: A61K 9/ (06.01) A61K 31/41 (06.01) (21) Application number: 116790.3 (22) Date of

More information

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES

FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER PVPK30 INCLUSION COMPLEXES Volume: 2: Issue-4: Oct - Dec -2011 ISSN 0976-4550 FORMULATION AND EVALUATION OF ETORICOXIB TABLETS EMPLOYING CYCLODEXTRIN- POLOXAMER 407 - PVPK30 INCLUSION COMPLEXES K.P.R. Chowdary*, K. Surya Prakasa

More information

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 Innovations in Design: NIA-West Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017 1 Innovations in Design: How Do You Stand Out? If all other competitors are the same

More information

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(6):42-46 Research Article ENHANCEMENT OF SOLUBILITY

More information

Technical brochure StarLac

Technical brochure StarLac T R TABLETING AC DIRECT COMPRESSION CO-PROCESSED LACTOSE Technical brochure MEGGLE co-processed lactose grades for direct compression: General information Direct compression (DC) tablet manufacture is

More information

SCIENTIFIC DISCUSSION

SCIENTIFIC DISCUSSION This part reflects the scientific knowledge and the information about this product available at the time of prequalification. Thereafter, updates may have become necessary which are included in parts 1

More information

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

Design and In-vitro Evaluation of Silymarin Bilayer Tablets CODEN (USA)-IJPRUR, e-issn: 2348-6465 International Journal of Pharma Research and Health Sciences Available online at www.pharmahealthsciences.net Original Article Design and In-vitro Evaluation of Silymarin

More information

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE Kantilal B. Narkhede *1, R. B. Laware 2, Y. P.

More information

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN Int. J. Chem. Sci.: 10(4), 2012, 2199-2208 ISSN 0972-768X www.sadgurupublications.com DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN K. V. R. N. S. RAMESH *, B. HEMA KIRNAMAYI

More information

( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1

( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / A1 THE LETTERIN US 20170231969A1 MUTTU 19 United States ( 12 ) Patent Application Publication ( 10 ) Pub. No.: US 2017 / 0231969 A1 Raneburger et al. ( 43 ) Pub. Date : Aug. 17, 2017 ( 54 ) PHARMACEUTICAL

More information

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN:

Int. Res J Pharm. App Sci., 2012; 2(6): ISSN: International Research Journal of Pharmaceutical and Applied Sciences (IRJPAS) Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2013; 3(1): 269-273 Research Article FORMULATION DEVELOPMENT

More information

STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS

STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS STARCHES FOR COSMETIC INDUSTRIES CORN PO4 PH B AND RICE NS AGRANA STARCH QUALITATIVE OPTIMIZATION OF COSMETIC EMULSIONS WITH CORN PO4 PH B OR RICE NS For many years CORN PO4 PH B and RICE NS (cross-linked

More information

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX Academic Sciences International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 4, Issue 1, 2012 Research Article FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE

More information

Available Online through Research Article

Available Online through Research Article ISSN: 0975-766X Available Online through Research Article www.ijptonline.com DESIGN AND EVALUATION OF GASTRORETENTIVE TABLETS FOR CONTROLLED DELIVERY OF NORFLOXOCIN Ganesh Kumar Gudas*, Subal Debnath,

More information

Enhanced delivery methods for greater efficacy

Enhanced delivery methods for greater efficacy On-Line Formulation Training - Anywhere In The World - Enhanced delivery methods for greater efficacy Belinda Carli Director, Institute of Personal Care Science Image showing absorbance in the outer stratum

More information

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007)

LIQUID PREPARATIONS FOR ORAL USE. Final text for addition to The International Pharmacopoeia (November 2007) November 2007 LIQUID PREPARATIONS FOR ORAL USE Final text for addition to The International Pharmacopoeia (November 2007) This monograph was adopted at the Forty-second WHO Expert Committee on Specifications

More information

KURARAY POVAL & EXCEVAL

KURARAY POVAL & EXCEVAL Characteristics Polyvinyl alcohol (PVOH) having varying degree of polymerization and. Recommended Uses Ranging from emulsion polymerization aid to binder for pigments in paper applications. Form supplied

More information

The binding performance of DFE Pharma Starch

The binding performance of DFE Pharma Starch The binding performance of DFE Pharma Starch MCC Starch Lactose Inhalation Superdisintegrants We are DFE Pharma We are the global leader in excipient solutions. We develop, produce and market excipients

More information

Folic Acid in Human Nutrition

Folic Acid in Human Nutrition Folic Acid in Human Nutrition Folic acid is a water soluble B vitamin widely distributed in foods. Deficiencies lead to impaired cell division and altered protein synthesis. Newborn children of women receiving

More information

Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs

Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs James E. Polli jpolli@rx.umaryland.edu April 26, 2016 Topics BCS Class 3 excipient study

More information

Functional Excipients for Suppository Applications

Functional Excipients for Suppository Applications Functional Excipients for Suppository Applications Skin Delivery Platform 2016 1 The Skin Delivery Platform Major areas of activity are in 4 pillars PLATFORM : SKIN DELIVERY Dermal Drug Delivery Mildness

More information

Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type

Table 1 Hydrophilicity of MC and HPMC Grades. Polymer Cloud Point ( C) Hydrophilicity MC HPMC Type 2910 HPMC Type PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-046-1 (Supersedes PTR-046) Page 1 of 6 Effect of Hypromellose and Methylcellulose Substitution Type, Molecular Weight and Drug Solubility

More information

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester

University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester University of Sulaimani School of Pharmacy Dept. of Pharmaceutics Third level - Second semester 5/21/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 1 Outlines Why rectal or vaginal route? Suppository

More information

SCIENTIFIC DISCUSSION. Efavirenz

SCIENTIFIC DISCUSSION. Efavirenz SCIENTIFIC DISCUSSION Name of the Finished Pharmaceutical Product: Manufacturer of Prequalified Product: Active Pharmaceutical Ingredient (API): Pharmaco-therapeutic group (ATC Code): Therapeutic indication:

More information